ArticleCancer research2020

HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer.

Sayuri Miyauchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.